Drips, the founders of Conversational Texting®, has secured a growth investment from the Blue Venture Fund. Drips enables healthcare organizations to connect with their members and patients during critical moments through its AI platform. The investment follows an investment from software investor Accel-KKR and its credit facility with Wells Fargo Capital Finance’s Technology Finance group.
The Blue Venture Fund is a collaboration among Blue Cross Blue Shield companies, the Blue Cross Blue Shield Association and Sandbox, to which thirty-five BCBS companies have committed over $890 million across four funds. Read more.
